��������

Earlier this year, launched , a new technology commercialization accelerator for faculty researchers interested in developing their inventions for the market. and of the Office of Technology Commercialization at UT Health are co-directors and mentors for the new program.

The first cohort graduated two therapeutics companies, spurred the development of four new medical devices, and included two digital health startups.

The companies are:

• Atomic Therapeutics, developing novel anticancer therapeutics for leukemia
• Protectum Oncology, introducing low-dose arsenic for reducing cancer therapy side effects
• EmergenceMed, an emergency medical suction device for obstructed airways
• CereNovum, Inc., a brain blood clot treatment device
• Diabetic Innovaitons, Inc., a compression device to stabilize the foot and ankle after surgery
• Pulse Strip, an audible pulse detection device
• AI+ Health, an artificial intelligence or AI-driven solution to chronic disease management, and
• Dencision, a dental and healthcare student assessment software as a service (SaaS) platform.

“This accelerator is the centerpiece of our efforts to build an entrepreneurial culture within the Health Science Center,” said Dr. Andrea Giuffrida, vice president for research at ��������. “Experienced mentors can help explain commercialization pathways for our researchers, while our postdocs and graduate students benefit from working with each team on their market strategies.”

Founders must first complete a validated technology commercialization process established with the Office of Technology Commercialization before entering the program, said John Gebhard, the assistant vice president
for the commercialization office. Each cohort will run annually from June through October, with a maximum of eight teams of founder-inventors joining the program. The accelerator does not require participants to pay a fee or exchange an equity share. , a joint program of �������� and The University of Texas at San Antonio, is funding the new accelerator program.

Fritz and Thompson recruited over a dozen mentors with specialized experience to work with the teams and invited accredited investors to participate in the final demo day for the program which was held Tuesday evening.

“We had 15 investors come tonight, with many more getting scheduled to meet with the teams in the coming weeks,” said Fritz. “We even had a company representative from the world’s largest manufacturer of spark plugs attend because he is looking at medical sensors that could be used to innovate their products.”